Why is "Oncology" trending?

Search Interest Perspective

• GSK CEO Follows Oncology Rivals’ Playbook in Search of Growth - Bloomberg.com
• GSK sees blockbuster potential in targeted cancer therapy after promising early data - Reuters
• Assessing Acupuncture Feasibility in the Oncology Treatment Paradigm - CancerNetwork
• Evolving Roles in Gynecologic Oncology: Balancing Surgery, Systemic Therapy and Team-Based Care - Cure Today
• SINGAPORE STRENGTHENS SARCOMA CARE THROUGH COORDINATED, MULTIDISCIPLINARY APPROACH - BioSpace
• Ann Barrett, oncologist who pioneered collaboration between different disciplines of cancer treatment - Yahoo
• Gilead pays $3.1B for Tubulis to bolster oncology ADC pipeline - Fierce Biotech
• Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline - Business Wire
• Ablative therapy improves overall survival for ‘supermassive’ bile duct tumors patients - Oncology Central
• 10 Must-Read Posts In GI Oncology This Week - Oncodaily
• Five Under 5: Top Oncology Videos for the Week of 4/5 - OncLive
• Protecting the cure: Why the future of radiation oncology must be precision-guided - The Cancer Letter
• Mount Sinai Department of Radiation Oncology Receives National 2026 BeRAD Professionalism Award - Mount Sinai
• The Targeted Pulse: Targeted Therapies and Treatment Optimization - Targeted Oncology
• Lancet Oncology Commission on Global Oncology Workforce Crisis Details Challenges, Calls for Action - ASCO Daily News
• Gilead (GILD), Tempus AI (TEM) Expand Multi-Year Oncology R&D Collaboration - Yahoo Finance
• New Adagene Immuno‑Oncology Tie‑Up Could Be A Game Changer For Incyte (INCY) - simplywall.st
• Closing the Trial Access Gap: Neuro-Symbolic AI and Oncology Trial Matching - CancerNetwork
• Precision Oncology in Action: Bridging Research and Policy at IQN Path, Naples – EAPM - Oncodaily
• Dr Hutchcraft on Putting Yourself on the Map in Gynecologic Oncology Through Social Media - OncLive
• Brian Mulherin: Excited to Present at Pioneering the Next Era of Oncology Care - Oncodaily
• Using Social Media to Build a Presence in Gynecologic Oncology - OncLive
• Why Treating Cancer Is Not Enough? The Missing Piece in Oncology Care: Interview with Dr. Konstantina Boniou - Oncodaily
• Hope, Uncertainty, and Hard Truths: The Complexity of Goals-of-Care Discussions in Oncology - OncLive
• GC-OS Abstract Submissions are Now Open – International Cardio-Oncology Society - Oncodaily
• From Pixels to Prescriptions: How AI Is Reshaping Pathology in Oncology - Medscape
• Two Phase 3 Trials That Changed Lung Cancer Treatment in 2025 - Oncodaily
• Liang Chang: 6 Top-Line Findings From a Decade of Oncology - Oncodaily
• Balazs Halmos: Launching Oncology AMA to Tackle Key Questions in Lung Cancer Care - Oncodaily
• Illumina (ILMN), Labcorp (LH) Expand Precision Oncology NGS Collaboration - Yahoo Finance
• Oncology Pulse Points: Multiple Myeloma ASCO-Ontario Living Guideline Updates - Pharmacy Times
• OCE Oncology Artificial Intelligence Program - fda.gov
• Oncology Biotech Updates This Week: Gilead's $5B ADC Acquisition, Tarlatamab's China Approval, and Why Biology Remains Biotech's True Bottleneck - Oncodaily
• Don't Believe The Google Prognosis: New Hope For Glioblastoma - Targeted Oncology
• Clinical Research Training Program for Oncology Professionals in Africa – ICF - Oncodaily
• Secondary extraocular extension of choroidal melanoma following primary photodynamic therapy - Nature
• Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWE - Business Wire
• Aaron Sverdlov: Early Bird Registration Remains Open for ESC Cardio-Oncology 2026 - Oncodaily
• Novel B7H3 ADC Yields Responses in Cervical Cancer and Platinum-Resistant Ovarian Cancer - CancerNetwork
• Examining Real-World Approaches for GPRC5D Bispecific in Multiple Myeloma - Targeted Oncology
• Nurses Urged to Avoid Age-Based Assumptions in Toxicity Care - Oncology Nursing News
• Cindy Crowninshield: Digital Twins are Moving from Concept to Action in Oncology - Oncodaily
• What Dogs Teach Us About Brain Tumors: The Untapped Power of Comparative Oncology - Oncodaily
• Adjuvant Therapy in Non-Clear Cell RCC - Targeted Oncology
• Lymphoma survivor returns to NYU Langone to lead pediatric oncology - Washington Square News
• Verastem Oncology’s combo shows two-year durability in ovarian cancer - Clinical Trials Arena
• Boston Oncology in cancer drug deal with China's Xuanzhu Biopharmaceutical - Reuters
• Does Stifel’s Focus on Ozekibart Milestones Reframe Inhibrx Biosciences' (INBX) Core Oncology Narrative? - simplywall.st
• Wafik S. El-Deiry: Inaugural National Caris Precision Oncology Alliance Meeting at Brown University - Oncodaily
• What 2026 Match Day Data Mean for Oncology - Oncology News Central
• RRH expanding oncology services, outpatient imaging with new projects - Spectrum News
• Fawzi Abu Rous: Final Call for the Detroit 2026 Hematology and Oncology Practice Symposium - Oncodaily
• Mark Lewis: How Not To Communicate As An Oncologist - Oncodaily
• 'It's incredible, like science fiction': How a new wave of immunotherapy is eliminating cancers - BBC
• Gilead’s Tubulis Deal Recasts Oncology Ambitions And HIV Reliance Risks - Yahoo Finance
• Strengthening International Collaboration in Oncology – Gustave Roussy - Oncodaily
• SIOG Research Masterclass 2026 Brings Together Experts in Geriatric Oncology - Oncodaily
• Oncology Mice Models Market Size to Expand from US$496.3 Mn - openPR.com
• Nationally recognized pediatric oncologist, physician–scientist, and lymphoma survivor - NYU Langone Health
• GSK presents positive data for B7-H4-targeted ADC in gynecological cancers - GSK
• Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023 - The Lancet
• New Commentary in Cancer on Palliative Care in Oncology - American Cancer Society Journals - Oncodaily
• Gilead Expands Oncology Pipeline With $5B Tubulis Deal - Yahoo Finance
• William Dale: SIOG and CARG Master Class in Geriatric Oncology - Oncodaily
• Amar Kishan: SHARP Consortium 2026 Update on SBRT for High-Risk Prostate Cancer - Oncodaily
• How Pfizer's Oncology Portfolio Is Shaping Up Before Q1 Results - Yahoo Finance
• Gilead Seizes Next-Generation ADC Powerhouse Tubulis in Landmark $5 Billion Oncology Acquisition - Oncodaily
• Douglas Flora: Challanges in Managing Predective Oncology and Anxiety of Foresight in Patients - Oncodaily
• FDA Issues Second CRL for RP1/Nivolumab in Advanced Melanoma - Targeted Oncology
• Holistic Care in Pediatric Oncology: Spotlight on Psycho-Oncology Across Europe - Oncodaily
• Precision Medicine in Early Oncology Trials: Biomarkers as Strategic Drivers - Pharmaceutical Technology
• New Survey Data Exploring Patient Experiences with Endometrial Cancer Care Presented at 2026 Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer - PR Newswire
• Robin Zon: Business of Oncology FLASCO 2026 Spring Conference - Oncodaily
• Amil Družić: Sarajevo OncoFem Talks to Highlight Advances in Women’s Oncology - Oncodaily
• Gilead Sciences (GILD) to Acquire Tubulis for $5B to Strengthen Oncology Pipeline - Yahoo Finance
• IDEAYA Biosciences to Announce Topline Results from Phase 2/3 OptimUM-02 Trial in Metastatic Uveal Melanoma on Monday, April 13, 2026 - BioSpace
• GSK CEO's 'scientific courage' propels plans for medley of phase 3 trials for Hansoh-partnered ADC - Fierce Biotech
• Why Cancer Care Fails in Conflict - European Medical Journal
• Oncology Reimbursement Undergoes “Significant Overhaul”: 9 Critical Changes to Know - Oncology News Central
• Douglas Flora invites you to OncoDaily Grand Rounds: AI in Oncology Edition - Oncodaily
• Passing of Greg Hannon Marks Loss of Visionary Leader in Oncology - Cancer Research UK Cambridge - Oncodaily
• How Pharma Is Outsourcing Oncology Target Discovery in 2026 - PharmTech.com
• New ASCO Guideline Tackles Disrespectful Patients, Other Communication Challenges - Oncology News Central
• Cartography Biosciences Advances Strategic Oncology Collaboration with Gilead’s First Option Target Exercise - Business Wire
• Waleed Arafat: Delighted to See This Collaboration Between ISCO and OncoDaily Come to Fruition! - Oncodaily
• Nurse Navigation, Reflex Testing Key to Closing Molecular Testing Gaps: Christopher D'Avella, MD - AJMC
• Navigating Cancer in Your 20s and 30s: Emotional Support for Young Adults - Cure Today
• Telix and Regeneron Strike Global Radiopharma Alliance in Precision Oncology Push - TipRanks
• Pepperdine Oncology Symposium 2026 - Pepperdine University
• Before the Clot Forms: Role of the IMPEDE VTE Score in Multiple Myeloma - Cancer Nursing Today
• Amil Družić: Global Survey for ASCO Health Policy Exploring Oncologists’ Professional Use of Social Media - Oncodaily
• Marriage linked to a lower risk of cancer - Oncology Central
• Verastem Oncology Announces Two-Year Median Follow-Up Data on AVMAPKI® FAKZYNJA® Combination Therapy (avutometinib capsules; defactinib tablets) in Recurrent Low-Grade Serous Ovarian Cancer at the SGO 2026 Annual Meeting on Women’s C - Business Wire
• The impact of AI on modern oncology from early detection to personalized cancer treatment | npj Precision Oncology - Nature
• Aurigene Oncology and Olema Pharmaceuticals patent KAT6A degradation inducers - BioWorld News
• Fumiko Ladd Chino: The Impact of Medicare Plan Design on Hospice Care in Oncology - Oncodaily
• H.C. Wainwright Raises its Price Target on Aktis Oncology (AKTS) to $33 - Insider Monkey
• Cancer Research UK–Funded International Accelerator Award 2026 - Oncodaily
• Oncology Leaders in the Spotlight: Rapid Roundup for February 2026 - Oncology News Central
• Pepperdine University to Host Inaugural Pepperdine Oncology Symposium - Pepperdine University